BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27977885)

  • 1. Soluble Adhesion Molecules During Ex Vivo Lung Perfusion Are Associated With Posttransplant Primary Graft Dysfunction.
    Hashimoto K; Cypel M; Kim H; Machuca TN; Nakajima D; Chen M; Hsin MK; Zamel R; Azad S; Waddell TK; Liu M; Keshavjee S
    Am J Transplant; 2017 May; 17(5):1396-1404. PubMed ID: 27977885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell-free DNA in human ex vivo lung perfusate as a potential biomarker to predict the risk of primary graft dysfunction in lung transplantation.
    Kanou T; Nakahira K; Choi AM; Yeung JC; Cypel M; Liu M; Keshavjee S
    J Thorac Cardiovasc Surg; 2021 Aug; 162(2):490-499.e2. PubMed ID: 32928548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Profile of Ex Vivo Lung Perfusate Yields Biomarkers for Lung Transplant Outcomes.
    Hsin MK; Zamel R; Cypel M; Wishart D; Han B; Keshavjee S; Liu M
    Ann Surg; 2018 Jan; 267(1):196-197. PubMed ID: 29240608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An observational study of Donor Ex Vivo Lung Perfusion in UK lung transplantation: DEVELOP-UK.
    Fisher A; Andreasson A; Chrysos A; Lally J; Mamasoula C; Exley C; Wilkinson J; Qian J; Watson G; Lewington O; Chadwick T; McColl E; Pearce M; Mann K; McMeekin N; Vale L; Tsui S; Yonan N; Simon A; Marczin N; Mascaro J; Dark J
    Health Technol Assess; 2016 Nov; 20(85):1-276. PubMed ID: 27897967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Higher M30 and high mobility group box 1 protein levels in ex vivo lung perfusate are associated with primary graft dysfunction after human lung transplantation.
    Hashimoto K; Cypel M; Juvet S; Saito T; Zamel R; Machuca TN; Hsin M; Kim H; Waddell TK; Liu M; Keshavjee S
    J Heart Lung Transplant; 2017 Jun; ():. PubMed ID: 28689646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and severity of primary graft dysfunction after lung transplantation using rejected grafts reconditioned with ex vivo lung perfusion.
    Boffini M; Ricci D; Bonato R; Fanelli V; Attisani M; Ribezzo M; Solidoro P; Del Sorbo L; Ranieri VM; Rinaldi M
    Eur J Cardiothorac Surg; 2014 Nov; 46(5):789-93. PubMed ID: 25061216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended post-ex vivo lung perfusion cold preservation predicts primary graft dysfunction and mortality: Results from a multicentric study.
    Leiva-Juárez MM; Urso A; Arango Tomás E; Lederer DJ; Sanchez P; Griffith B; Davis RD; Daneshmand M; Hartwig M; Cantu E; Weyant MJ; Bermudez C; D'Cunha J; Machuca T; Wozniak T; Lynch W; Nemeh H; Mulligan M; Song T; Jessen M; Camp PC; Caldeira C; Whitson B; Kreisel D; Ramzy D; D'Ovidio F
    J Heart Lung Transplant; 2020 Sep; 39(9):954-961. PubMed ID: 32475748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of interleukin-1β as a predictive biomarker and potential therapeutic target during clinical ex vivo lung perfusion.
    Andreasson ASI; Borthwick LA; Gillespie C; Jiwa K; Scott J; Henderson P; Mayes J; Romano R; Roman M; Ali S; Fildes JE; Marczin N; Dark JH; Fisher AJ;
    J Heart Lung Transplant; 2017 Sep; 36(9):985-995. PubMed ID: 28551353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated donor plasminogen activator inhibitor-1 levels and the risk of primary graft dysfunction.
    Hamilton BCS; Dincheva GR; Zhuo H; Golden JA; Brzezinski M; Singer JP; Matthay MA; Kukreja J
    Clin Transplant; 2018 Apr; 32(4):e13210. PubMed ID: 29377268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A CLUE for better assessment of donor lungs: Novel technique in clinical ex vivo lung perfusion.
    Ayyat KS; Okamoto T; Niikawa H; Sakanoue I; Dugar S; Latifi SQ; Lebovitz DJ; Moghekar A; McCurry KR
    J Heart Lung Transplant; 2020 Nov; 39(11):1220-1227. PubMed ID: 32773324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of lung edema during ex-vivo lung perfusion by single transpulmonary thermodilution: A preliminary study in humans.
    Trebbia G; Sage E; Le Guen M; Roux A; Soummer A; Puyo P; Parquin F; Stern M; Pham T; Sakka SG; Cerf C;
    J Heart Lung Transplant; 2019 Jan; 38(1):83-91. PubMed ID: 30391201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary graft dysfunction.
    Criner RN; Clausen E; Cantu E
    Curr Opin Organ Transplant; 2021 Jun; 26(3):321-327. PubMed ID: 33938469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with the first 50 ex vivo lung perfusions in clinical transplantation.
    Cypel M; Yeung JC; Machuca T; Chen M; Singer LG; Yasufuku K; de Perrot M; Pierre A; Waddell TK; Keshavjee S
    J Thorac Cardiovasc Surg; 2012 Nov; 144(5):1200-6. PubMed ID: 22944089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local complement activation is associated with primary graft dysfunction after lung transplantation.
    Kulkarni HS; Ramphal K; Ma L; Brown M; Oyster M; Speckhart KN; Takahashi T; Byers DE; Porteous MK; Kalman L; Hachem RR; Rushefski M; McPhatter J; Cano M; Kreisel D; Scavuzzo M; Mittler B; Cantu E; Pilely K; Garred P; Christie JD; Atkinson JP; Gelman AE; Diamond JM
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32750037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Extravascular Lung Water and Plasma Biomarkers of Acute Lung Injury Precede Oxygenation Impairment in Primary Graft Dysfunction After Lung Transplantation.
    Pottecher J; Roche AC; Dégot T; Helms O; Hentz JG; Schmitt JP; Falcoz PE; Santelmo N; Levy F; Collange O; Uring-Lambert B; Bahram S; Schaeffer M; Meyer N; Geny B; Lassalle P; Diemunsch P; Massard G; Kessler R; Steib A;
    Transplantation; 2017 Jan; 101(1):112-121. PubMed ID: 27495752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Perioperative Lung Transplant Virome: Torque Teno Viruses Are Elevated in Donor Lungs and Show Divergent Dynamics in Primary Graft Dysfunction.
    Abbas AA; Diamond JM; Chehoud C; Chang B; Kotzin JJ; Young JC; Imai I; Haas AR; Cantu E; Lederer DJ; Meyer KC; Milewski RK; Olthoff KM; Shaked A; Christie JD; Bushman FD; Collman RG
    Am J Transplant; 2017 May; 17(5):1313-1324. PubMed ID: 27731934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of TGF-β in the Association Between Primary Graft Dysfunction and Bronchiolitis Obliterans Syndrome.
    DerHovanessian A; Weigt SS; Palchevskiy V; Shino MY; Sayah DM; Gregson AL; Noble PW; Palmer SM; Fishbein MC; Kubak BM; Ardehali A; Ross DJ; Saggar R; Lynch JP; Elashoff RM; Belperio JA
    Am J Transplant; 2016 Feb; 16(2):640-9. PubMed ID: 26461171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of donor related lung injury in clinical lung transplantation using a validated ex vivo lung perfusion inflammation score.
    Sage AT; Richard-Greenblatt M; Zhong K; Bai XH; Snow MB; Babits M; Ali A; Baciu C; Yeung JC; Liu M; Cypel M; Kain KC; Keshavjee S
    J Heart Lung Transplant; 2021 Jul; 40(7):687-695. PubMed ID: 33781664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between plasma lipid peroxidation products and primary graft dysfunction after lung transplantation is modified by donor smoking and reperfusion hyperoxia.
    Diamond JM; Porteous MK; Roberts LJ; Wickersham N; Rushefski M; Kawut SM; Shah RJ; Cantu E; Lederer DJ; Chatterjee S; Lama VN; Bhorade S; Crespo M; McDyer J; Wille K; Orens J; Weinacker A; Arcasoy S; Shah PD; Wilkes DS; Hage C; Palmer SM; Snyder L; Calfee CS; Ware LB; Christie JD;
    J Heart Lung Transplant; 2016 Apr; 35(4):500-507. PubMed ID: 26856667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transplantation after ex vivo lung perfusion: A midterm follow-up.
    Wallinder A; Riise GC; Ricksten SE; Silverborn M; Dellgren G
    J Heart Lung Transplant; 2016 Nov; 35(11):1303-1310. PubMed ID: 27381674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.